Details for 2016826557

Up to date per 05.04.2026

Actions

Title / Product Name

KOMBINATION AUS ANTI-PD-1-ANTIKÖRPERN UND BISPEZIFISCHEN ANTI-CD20/ANTI-CD3-ANTIKÖRPERN ZUR BEHANDLUNG VON KREBS

Status

Granted/Registered

Protection Type

European Patent

(AT-) Application Number

2016826557

EP Publication Number

3394103

E-Number

1582191

Language

PCT Number

US16068030

Publication Date

31.10.2018 A

28.06.2023 B1

Registration Date

28.06.2023

AT Publication Date

15.07.2023

Application Date

21.12.2016

Registration Number

Priorities

22.12.2015

201562270749 P

IPC

A61P 35/02 20060101AFI20221208BHEP

Maximum Duration of Protection

21.12.2036

Owner

Regeneron Pharmaceuticals, Inc.777 Old Saw Mill River Road Tarrytown, NY 10591US

Representative

Patentanwaltskanzlei Matschnig & Forsthuber OGBiberstraße 221010 WienAT

Inventor

VARGHESE, BinduC/o Regeneron Pharmaceuticals Inc. 777 Old Saw Mill River Road Tarrytown NY 10591US

THURSTON, GavinC/o Regeneron Pharmaceuticals Inc. 777 Old Saw Mill River Road Tarrytown NY 10591US

LOWY, IsraelC/o Regeneron Pharmaceuticals Inc. 777 Old Saw Mill River Road Tarrytown NY 10591US

BROWNSTEIN, CarrieC/o Regeneron Pharmaceuticals Inc. 777 Old Saw Mill River Road Tarrytown NY 10591US

Information about Fees